Skip to content
Screener

Medtronic MDT Cardiovascular — Depreciation

Other segment segments

Neuroscience
$85M+18.1%
Medical Surgical
$56M+5.7%
Diabetes
$32M+6.7%
Other operating segment
$0

Similar metrics at other companies

Boston Scientific logo
BSXCardiovascular — Depreciation
$89M+14.1%
Danaher logo
DHRBiotechnology — Depreciation
$40M+5.3%
Danaher logo
DHRDiagnostics — Depreciation
$107M+7.0%
Comfort Systems USA logo
FIXMechanical — Depreciation
$16.41M+35.7%
GLW
GLWAutomotive — Depreciation
$39M-4.9%
GLW
GLWSolar — Depreciation
$77M+196%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions)Total Assets / April 24, 2026Total Assets / April 25, 2025Depreciation Expense / 2026Depreciation Expense / 2025Depreciation Expense / 2024
Cardiovascular$17,553$16,548$253$225$199
Neuroscience18,51418,476320282252
Medical Surgical32,53533,317225205194
Total reportable segments68,60268,340798711645
Other operating segments (1)4,8274,43312711394
Corporate19,59818,906261229215
Total$93,028$91,680$1,186$1,054$954

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's cardiovascular — depreciation?
Medtronic (MDT) reported cardiovascular — depreciation of $67M in Q1 2026.
How has Medtronic's cardiovascular — depreciation changed year-over-year?
Medtronic's cardiovascular — depreciation increased by 15.5% year-over-year, from $58M to $67M.
What is the long-term trend for Medtronic's cardiovascular — depreciation?
Over 4 years (2022 to 2026), Medtronic's cardiovascular — depreciation has grown at a 4.8% compound annual growth rate (CAGR), from $210M to $253M.
What does cardiovascular — depreciation mean?
This represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities, used by the cardiovascular segment over their useful lives. It is a non-cash expense that reflects the wear and tear of the segment's physical capital. Tracking this helps in understanding the capital intensity of the cardiovascular business.

Ask your AI about Medtronic's cardiovascular — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude